PERITONEAL CANCER
Clinical trials for PERITONEAL CANCER explained in plain language.
Never miss a new study
Get alerted when new PERITONEAL CANCER trials appear
Sign up with your email to follow new studies for PERITONEAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to extend life in ovarian cancer
Disease control Recruiting nowThis study tests whether adding bevacizumab to niraparib after standard chemotherapy works better than niraparib alone for women with newly diagnosed advanced ovarian, fallopian tube, or peritoneal cancer. About 970 participants will be randomly assigned to one of two treatment p…
Matched conditions: PERITONEAL CANCER
Phase: PHASE3 • Sponsor: AGO Study Group • Aim: Disease control
Last updated May 17, 2026 00:50 UTC
-
New drug combo aims to control hard-to-treat ovarian cancer
Disease control Recruiting nowThis early-phase study tests a new drug called azenosertib (ZN-c3) combined with standard chemotherapy or bevacizumab in people with ovarian, peritoneal, or fallopian tube cancer that has stopped responding to platinum-based treatment. The main goals are to find safe doses and ch…
Matched conditions: PERITONEAL CANCER
Phase: PHASE1 • Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc • Aim: Disease control
Last updated May 17, 2026 00:44 UTC
-
New trick may slash transfusions in ovarian cancer surgery
Disease control Recruiting nowThis study tests a technique called acute normovolemic hemodilution (ANH) during ovarian cancer surgery. Before surgery, some blood is removed and replaced with fluids, then returned later. The goal is to see if this reduces the need for donor blood transfusions. About 86 adults …
Matched conditions: PERITONEAL CANCER
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 12, 2026 13:41 UTC
-
New drug combo aims to keep ovarian cancer at bay
Disease control Recruiting nowThis study is testing whether a combination of two drugs, mirvetuximab soravtansine and olaparib, can help keep recurrent ovarian, peritoneal, or fallopian tube cancer from growing back after initial treatment. The trial involves 53 women whose cancer has returned but still respo…
Matched conditions: PERITONEAL CANCER
Phase: PHASE2 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated May 11, 2026 20:46 UTC
-
New drug combo aims to extend remission in recurrent ovarian cancer
Disease control Recruiting nowThis study tests whether adding mirvetuximab soravtansine to standard maintenance therapy (bevacizumab) can delay cancer regrowth in people with a specific type of ovarian, fallopian tube, or peritoneal cancer. Participants must have cancer that responded to initial platinum-base…
Matched conditions: PERITONEAL CANCER
Phase: PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated May 04, 2026 16:24 UTC
-
Virtual reality goggles could be new tool against cancer pain
Symptom relief Recruiting nowThis study tests whether using virtual reality (VR) can reduce severe belly pain in people with digestive tract cancers. 360 participants will be split into three groups: one using skills-based VR, one using distraction VR, and a sham control group. Researchers will track pain, a…
Matched conditions: PERITONEAL CANCER
Phase: NA • Sponsor: Cedars-Sinai Medical Center • Aim: Symptom relief
Last updated May 08, 2026 12:03 UTC
-
Aspirin may boost ovarian cancer treatment, early study hopes
Symptom relief Recruiting nowThis early-phase study is testing whether adding aspirin to standard chemotherapy can reduce immune-suppressing cells inside ovarian, fallopian tube, or peritoneal tumors. About 100 women will take aspirin alongside their chemo before surgery. The goal is to see if this simple, l…
Matched conditions: PERITONEAL CANCER
Phase: EARLY_PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Symptom relief
Last updated May 04, 2026 16:19 UTC
-
New study aims to predict survival in ovarian cancer patients
Knowledge-focused Recruiting nowThis study is collecting information from 371 people with advanced ovarian, peritoneal, or fallopian tube cancer to find out which factors affect how long they live. Researchers will look at patient details like age and health, as well as tumor features like genetics and cell typ…
Matched conditions: PERITONEAL CANCER
Phase: NA • Sponsor: Centre Oscar Lambret • Aim: Knowledge-focused
Last updated May 14, 2026 12:06 UTC